The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Proof of concept of immuno-PET molecular imaging of met using 76Br- and 89Zr-labeled MetMAb.
M. Merchant
Employment or Leadership Position - Genentech
Stock Ownership - Roche
J. Marik
Employment or Leadership Position - Genentech
Stock Ownership - Roche
J. Peng
Employment or Leadership Position - Genentech
Stock Ownership - Roche
S. P. Williams
Employment or Leadership Position - Genentech
Stock Ownership - Roche
A. Ogasawara
Employment or Leadership Position - Genentech
Stock Ownership - Roche
J. N. Tinianow
Employment or Leadership Position - Genentech
Stock Ownership - Roche
V. Bhadrasetty
No relevant relationships to disclose
L. Lang
No relevant relationships to disclose
S. M. Lee
No relevant relationships to disclose
I. Kim
No relevant relationships to disclose
M. Williams
No relevant relationships to disclose
L. Szajek
No relevant relationships to disclose
K. E. Raffensperger
No relevant relationships to disclose
F. Cecchi
No relevant relationships to disclose
E. Jagoda
No relevant relationships to disclose
P. L. Choyke
No relevant relationships to disclose
C. Paik
No relevant relationships to disclose
D. P. Bottaro
No relevant relationships to disclose